Nanoligent
Developer of nanotechnology-based anti-cancer treatments intended to treat different types of metastatic cancer. The company utilizes protein engineering and nanobiotechnology to create self-assemblin...
Valuation
$0
Share Price
N/A
Total Raised
$18M
Last Round
N/A